UPDATE 1-U.S. FDA approves BioMarin's genetic disorder drug Vimizim
February 14, 2014 at 16:25 PM EST
Feb 14 (Reuters) - The U.S. Food and Drug Administration said on Friday it has approved the first drug to treat Morquio A Syndrome, a rare genetic disorder that causes skeletal malformation and a variety of related lung, eye, ear and heart problems.
